CALLOS ANDREW (Chief Commercial Officer) sold 5.2% of their position (3.64K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $236.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/31/2026ACC: 0001061983-26-000030
Officer· Chief Commercial Officer
Since Mar 2021
-3.64K
Net shares
Net seller
$236.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.64K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.64K
Price / share
$65.00
Trade value
$236.53K
% of position
5.2%
3/31/2026
69.64K→66K
Total
Net shares
−3.64K
Net value
-$236.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2026 | S · Sale | −3.64K | $65.00 | $236.53K | 5.2% | 69.64K | 66K |
| Total | −3.64K | -$236.53K | ||||||
Derivative Transactions0
No derivative transactions reported